- Home
- HUMAW vs DLB Comparison
HUMAW vs DLB Comparison
Compare HUMAW & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMAW
- DLB
- Stock Information
- Founded
- HUMAW N/A
- DLB 1965
- Country
- HUMAW United States
- DLB United States
- Employees
- HUMAW 185
- DLB N/A
- Industry
- HUMAW Biotechnology: Pharmaceutical Preparations
- DLB Multi-Sector Companies
- Sector
- HUMAW Health Care
- DLB Miscellaneous
- Exchange
- HUMAW Nasdaq
- DLB Nasdaq
- Market Cap
- HUMAW N/A
- DLB N/A
- IPO Year
- HUMAW 2020
- DLB 2005
- Fundamental
- Price
- HUMAW $1.33
- DLB $78.26
- Analyst Decision
- HUMAW
- DLB Strong Buy
- Analyst Count
- HUMAW 0
- DLB 3
- Target Price
- HUMAW N/A
- DLB $99.33
- AVG Volume (30 Days)
- HUMAW N/A
- DLB 609.2K
- Earning Date
- HUMAW N/A
- DLB 01-30-2025
- Dividend Yield
- HUMAW N/A
- DLB 1.69%
- EPS Growth
- HUMAW N/A
- DLB 31.22
- EPS
- HUMAW N/A
- DLB 2.69
- Revenue
- HUMAW N/A
- DLB $1,273,721,000.00
- Revenue This Year
- HUMAW N/A
- DLB $7.48
- Revenue Next Year
- HUMAW N/A
- DLB $4.53
- P/E Ratio
- HUMAW N/A
- DLB $29.04
- Revenue Growth
- HUMAW N/A
- DLB N/A
- 52 Week Low
- HUMAW N/A
- DLB $66.35
- 52 Week High
- HUMAW N/A
- DLB $87.12
- Technical
- Relative Strength Index (RSI)
- HUMAW N/A
- DLB 50.38
- Support Level
- HUMAW N/A
- DLB $77.02
- Resistance Level
- HUMAW N/A
- DLB $80.38
- Average True Range (ATR)
- HUMAW 0.00
- DLB 1.45
- MACD
- HUMAW 0.00
- DLB -0.35
- Stochastic Oscillator
- HUMAW 0.00
- DLB 27.27
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.